CONTACT
NAVARRA
+34 948 194 700
NAVARRA
×
INTRANET
PEOPLE FINDER
English
Español
WORK WITH US
INVESTOR AREA
/servlet/autocompletar/
Delete
DO YOU WANT TO HELP US?
ÚNETE A NUESTRO EQUIPO
ÁREA DE INVERSIÓN
About us
Universidad de Navarra Biomedical Campus
Research Center of the Clínica
Organization
Transparency Portal
Corporate Responsibility (Compliance)
Research
Diseases
Research divisions
Research groups
Technological platforms
Research and clinical trials
Research Staff
Human Resources Strategy for Researchers (HRS4R)
Scientific activity
Innovation
Pipeline
Patents
Entrepreneurship | Spin off
Collaboration with companies
Investor Area
Training
Master's Degrees
Doctorate Programs
Training stays
Training contracts and grants
Collaborate with us
How to collaborate
Collaboration projects
Collaborating companies
Transparency
News
News
Events
Scientific Report 2022-23
Health and Science
Home
>
News
>
News
Cima Universidad de Navarra news
Specialties
Choose by department
Adhesion and Metastasis
Adoptive Cell Therapy
Adoptive Cellular Therapy
Advanced Therapies for Pediatric Solid Tumors
Advanced Therapies for Rare Liver Diseases
Animal Models
Animal Production and Experimentation
Applied and Translational Onco-Immunology
Aptámeros y Química Médica
Aptamers
Atherothrombosis
Biobank
Biochemical Analysis and Cell Metabolism
Bioinformatics
Biomedical Engineering
Cancer Division
Cancer gene therapy
Cardiac Tissue Engineering
Cardiovascular Diseases
Combination Strategies for Translational Immunotherapy
Computational Biology and Translational Genomics
Cytokine-Based Therapeutics
Cytometry
DNA and RNA Medicine
Dynamics of the antitumor immune response
Enable Technologies
Epigenetics
Epilepsy
Gene Therapy for Hereditary Hearing Loss and AAV Engineering
Gene Therapy for Monogenic Encephalopathies
Gene Therapy for Rare Diseases
Gene Therapy in Neurological Diseases
Gene Therapy in Neurological Disorders
Gene Therapy in Parkinson's Disease
Gene Therapy of Renal Diseases and Study of N-terminal Acetylation of Proteins
Genomics Unit
Heart Failure
Hemato-Oncology
Hepatology
Hepatology: Liquid Biopsy and Carcinogenesis
Hepatology: Metabolism, Epigenetics and Carcinogenesis
Hepatology: Molecular Mechanisms and Targets in liver carcinogenesis
Hepatology: Porphyrias and Carcinogenesis
Image
Immune Therapies
Immunology and Immunotherapy
Immunomodulation and Tumor Microenvironment
In vivo Organ Generation by Stem Cells
Locoregional Immunotherapy Strategies in Peritoneal Carcinomatosis
Lungsearch: Lung cancer Screening, Early detection, biomarkers and new therapeutic targets
Lymphomas
Machine Learning in Biomedicine
Medicinal Chemistry
Micro-PET
Microbiome and Clinical Physiology
Microphysiological Systems and Quantitative Biology
Morphology
Myelodysplastic Neoplasia
Myeloid Pathology
Neuroscience
Next Generation Gene Delivery Technologies
Non-coding RNA and Biotechnology
Non-Coding RNA and Cancer Genome
Oncogenes and Effector Targets
Peptide
Physiological Control and Monitoring
Preclinical Models and Analysis Tools
Predictive Response Marker
Radioactive Facility
Radioimmunotherapy strategies for pediatric tumors
Regulación de la Expresión Génica
Renal Gene Therapy and Chimeric AAV Development
RNA and Senescence
RNA Biology and Therapy
Solid Tumor
Stress Responses and Liver Cancer Immunotherapy
Therapeutic Innovation
Therapeutic Innovation in Lung Cancer
Translational Hematology
Translational Immunomics in Hematological Neoplasms
Translational Oncology
Tumor Evasion and New Targets
Vaccine Development
Date from
Date to
Un proyecto del Cima Universidad de Navarra, seleccionado por el Consejo Europeo de Investigación (ERC) para impulsar una nueva terapia de RNA para el cáncer colorrectal
La ayuda, de 150.000 euros, se engloba dentro de Horizonte Europa, el programa marco de investigación e innovación (I+I) de la Unión Europea (UE)
July 15, 2025
La estimulación del sistema inmune mejora el tratamiento con virus en modelos animales del tumor cerebral infantil más agresivo
Investigadores del Cima confirman que la administración intratumoral del virus Delta-24-RGD y la activación de células dendríticas abren una vía terapéutica para los pacientes con glioma difuso de línea media
July 1, 2025
Una nueva combinación terapéutica mejora la eficacia de la inmunoterapia en tumores sólidos
Investigadores del Cima Universidad de Navarra descubren que la administración de reguladores epigenéticos e inductores de muerte celular prolonga la supervivencia en modelos animales de cáncer
June 24, 2025
El CCUN se alía con 25 hospitales para usar IA en la mejora del tratamiento de los síndromes mielodisplásicos
El Cancer Center Clínica Universidad de Navarra participa en un proyecto nacional que analizará información genética y molecular con inteligencia artificial para favorecer la investigación en torno a este trastorno de la médula ósea
June 20, 2025
Los hematólogos europeos premian al Dr. Jesús San Miguel por toda su vida profesional
El congreso de la Asociación Europea de Hematología en Milán señala con su
EHA Lifetime Achievement Award
las contribuciones a la especialidad del consultor senior del Cancer Center Clínica Universidad de Navarra
June 13, 2025
Identifican un ARN que regula el metabolismo de las células senescentes
El estudio del Cima Universidad de Navarra abre nuevas vías a terapias contra el cáncer y el envejecimiento
June 10, 2025
